The US represents the world’s largest healthcare market, with a high annual healthcare spending. The growth in healthcare spending is mainly driven by high administrative costs, and expensive hospital care. We believe that the market holds a great potential with several segments under healthcare spending still remaining untapped, indicating immense opportunities for the industry players for expanding operations. According to our report “US Healthcare Market Outlook 2013”, the US healthcare spending is expected to grow at a CAGR of around 5% during 2010-2013.
Our report covers the Hospital care, Pharmaceutical, Medical device, Healthcare IT and Healthcare Insurance segments of the industry. Among several market attractions in the US healthcare sector, M-health has been gaining increasing market penetration, and is poised for a high future growth. Due to increasing prevalence of chronic diseases and rising aging population, the healthcare facilities are in great demand leading to growth in the sector.
The pharmaceutical market is a growing segment, with several global players playing a major role. Our report gives a brief profile of these players, and emphasizes the future growth of the pharma market. It also elaborates how the latest technological advancements, which will make treatment and diagnosis simpler and effective, would impact the medical device market.
However, the country faces some severe setbacks in the industry. The research highlights the shortage of healthcare professionals which can impact the US healthcare industry in the future. It also covers how the government is striving to combat these issues.
The healthcare sector is regulated by the government, and the report covers several legislations prevailing in the industry. How the government has been trying to improve the healthcare sector performance by introducing several reforms, including The Affordable Care Act of 2010, has also been discussed along with its impact on the performance of each segment.
The report provides detailed statistical and analytical review of demographics, disease profiles, and key drivers affecting the US healthcare sector. It contains exhaustive information that will facilitate clients to draw up market strategies and assess opportunities in the US healthcare market.
